Staidson BioPharm

300204
16.701.94% ( -0.33 )
Delay Trading: Nov 16, 10:50:00

Financials

Q3 2026 Earnings

Financial report interval: 2026.06.30 - 2026.09.30

Overview: Staidson BioPharm(300204) the Revenue is 54.29 M (-1.19%);the EBIT is -11 M (-107.2%);the EPS is -0.0307 (-178.2%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.05B1.19%
----
----
EBIT
-0.01B107.21%
----
----
EPS
-0.0307178.24%
----
----

Upcoming earnings report - FY2026 Annual Earning Release

Available dateMar 26, 2027
Estimate Revenue471.15 M
Estimate EBIT13.75 M
Estimate EPS0.03

Revenue

ActualEstimateUnit: CNY
Quarterly

EBIT

ActualEstimateUnit: CNY
Quarterly

Net income

ActualEstimateUnit: CNY
Quarterly

EPS

ActualEstimateUnit: CNY
Quarterly